Clinical Trials Directory

Trials / Completed

CompletedNCT02226302

Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
16 (estimated)
Sponsor
Queensland Centre for Gynaecological Cancer · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The objective is to develop an organotypic model to assess the effects of obesity on the expression and methylation status of estrogen-responsive genes in endometrial cancer. Omental fat samples will be removed from participants during surgery and these fat samples will be used in laboratory analyses.

Conditions

Timeline

Start date
2014-07-01
Primary completion
2018-05-01
Completion
2021-08-01
First posted
2014-08-27
Last updated
2021-09-09

Locations

2 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT02226302. Inclusion in this directory is not an endorsement.